About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)

A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)

NCT00902369·12 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Asahi Kasei Therapeutics Corporation

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Diagnosis of RA (class I to III)
Stable dose of methotrexate (at least 12 weeks)

You may not be if

Pregnant or breastfeeding
Abnormal screening laboratory test values considered to be clinically significant

The record

StatusCompleted

PhasePhase 2

Taking part130

StartedMay 2009

UpdatedJul 25, 2016

Conditions

Rheumatoid Arthritis

Where12

Hlučín, Czechia
Prague, Czechia
Uherské Hradiště, Czechia